2022-501019-15-00招募中2 期
Phase I/II study assessing radioligand therapy (RLT) using 177Lu-PentixaTher for relapsed/refractory CXCR4+ acute leukemia.
Centre Hospitalier Universitaire De Nantes4 个研究点 分布在 1 个国家目标入组 21 人开始时间: 2024年3月25日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 21
- 试验地点
- 4
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Pr Patrice CHEVALLIER
Scientific
Centre Hospitalier Universitaire De Nantes
研究点 (4)
Loading locations...
相似试验
招募中
1 期
A dosimetry trial of uPAR targeted radioligand therapy in patients with glioblastomaGlioblastoma2024-520105-39-00Curasight A/S6
招募中
3 期
RACE-trial: Neoadjuvant Radiochemotherapy versus Chemotherapy for Patients with Locally Advanced, Potentially Resectable Adenocarcinoma of the Gastroesophageal Junction (GEJ)
A randomized phase III joint study of the AIO, ARO and DGAV2024-516271-32-00Universitat Heidelberg342
招募中
2 期
Radiometabolic Therapy (RMT) with 177Lu PSMA in PSMA PET/CT positive advanced/metastatic tumours: a basket trial (LUBASKET)2024-519346-75-00Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori IRST S.r.l.83
招募中
不适用
A phase I/II clinical trial of radical radiotherapy using carbon-ion beams with standard adjuvant therapy for early breast cancerbreast cancerJPRN-UMIN000029478QST Hospital, National Institutes for Quantum and Radiological Sciences and Technology30
招募中
1 期
A phase I/II clinical trial of radical radiotherapy using carbon-ion beams with standard adjuvant therapy for early breast cancerD001943Breast cancerJPRN-jRCTs032180154Karasawa Kumiko30